The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
In this session, the strategies/approaches to address the challenges of accelerated CMC development for new modalities will be discussed, based on recent experiences with fast-to–market of vaccines and therapeutics for COVID-19…
Continuous Manufacturing (CM) of biologics has been a hot topic for recent years because it has a potential for improving the efficiency, agility, and flexibility of drug substance and drug product manufacturing…